113
Views
4
CrossRef citations to date
0
Altmetric
Articles

Green Synthesis of Dihydropyrimidine Annulated Heterocyclic Systems Catalyzed by Nanoporous Na+-Montmorillonite Perchloric Acid and Evaluation of Their Biological Activities

, , &
Pages 1417-1433 | Received 11 Sep 2017, Accepted 24 Nov 2018, Published online: 22 Jan 2019
 

Abstract

An efficient and environmentally benign method for the green one-pot synthesis of dihydrobenzoimidazolo pyrimidine derivatives has been developed by multi-component reaction of 2-aminobenzimidazole, ethyl acetoacetate or malononitrile and aromatic aldehydes using nanoporous Na+-montmorillonite perchloric acid as a novel heterogeneous solid acid catalyst. The catalyst was easily prepared and characterized by X-ray powder diffraction, FTIR, SEM-EDX, TGA, BET, nitrogen adsorption–desorption measurements, pH analysis, and Hammett acidity function. Also, the antibacterial activity of synthesized compounds was evaluated and some products showed good activity. Availability and low cost of the reagent, ease of preparation and reusability of the catalyst, short reaction times, high yields of the products, operational simplicity, and solvent-free reaction conditions are some of the main advantages of this novel synthetic method.

Additional information

Funding

We are thankful to the University of Guilan Research Council for the partial support of this work.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.